Which of the following is NOT a use of toxicology and adverse event data?

• A. Stop Development Or Remove A Drug From The Market
• B. Identify What Adverse Effects A Drug Produces
• C. Determine The Price Of The Drug
• D. Provide Info About Drug Combinations That Should Be Avoided

Answer: (C)

Safety data from toxicology and adverse events guide how a drug is developed and used. They help determine if a compound should move forward in development, be paused, or be withdrawn from the market when risks outweigh benefits. They also reveal the specific adverse effects the drug can cause, so clinicians know what to monitor and how to manage risks. Additionally, these data inform safety labeling and recommendations about when certain drug combinations should be avoided because interactions can raise risk.

Pricing, on the other hand, is driven by economic and strategic factors—development and manufacturing costs, market competition, payer negotiations, and access considerations. Safety data themselves do not set the price, even though a strong safety profile can influence marketability indirectly.